Home › Funds › ACORN CAPITAL ADVISORS, LLC › ENGN
ACORN CAPITAL ADVISORS, LLC position in ENGN
ENGENE THERAPEUTICS INC · Health Care
ACORN CAPITAL ADVISORS, LLC reported holding 3,811,782 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.6M, representing 2.09% of its reported portfolio and ranking #11 among its reported holdings. ACORN CAPITAL ADVISORS, LLC has disclosed ENGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACORN CAPITAL ADVISORS, LLC's ENGN position evolved
ACORN CAPITAL ADVISORS, LLC first disclosed a stake in ENGN in Q2 2026 at 1,271,257 shares (US$2.2M). The position peaked in Q3 2026 at 3,811,782 shares, worth US$7.6M. Across 2 filings, ACORN CAPITAL ADVISORS, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,811,782 shares valued at US$7.6M — an increase of 2,540,525 shares quarter over quarter.. Notable position changes include a 200% increase in Q3 2026 (shares rose 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.27M | $2.20M | New |
| Q3 2026 | 3.81M | $7.62M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENGN and 13F data
ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 26 other funds we track also report a position in ENGN — the largest reported positions include FCPM III SERVICES B.V. (US$19.3M), BML Capital Management, LLC (US$13.3M), Nextech Invest Ltd. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENGN
- FCPM III SERVICES B.V. 9.63M sh · $19.27M · Q3 2026
- BML Capital Management, LLC 6.67M sh · $13.34M · Q3 2026
- Nextech Invest Ltd. 2.32M sh · $4.02M · Q2 2026
- Peapod Lane Capital LLC 1.04M sh · $2.08M · Q3 2026
- Omega Fund Management, LLC 876.36K sh · $1.75M · Q3 2026
- Aldebaran Capital, LLC 657.32K sh · $1.31M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 747.75K sh · $1.29M · Q2 2026
- Kynam Capital Management, LP 457.86K sh · $915.71K · Q3 2026
- Elmind Capital, LP 210.00K sh · $363.30K · Q2 2026
More on ACORN CAPITAL ADVISORS, LLC
FAQ
How long has ACORN CAPITAL ADVISORS, LLC held ENGN?
ACORN CAPITAL ADVISORS, LLC has disclosed ENGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ACORN CAPITAL ADVISORS, LLC's current position in ENGN?
As of Q3 2026, ACORN CAPITAL ADVISORS, LLC holds 3.81M shares of ENGN (ENGENE THERAPEUTICS INC), valued at $7.62M, representing 2.09% of its reported portfolio and ranking #11.
Has ACORN CAPITAL ADVISORS, LLC been buying or selling ENGN?
In the latest 13F filing (Q3 2026), ACORN CAPITAL ADVISORS, LLC increased its position in ENGN. The position peaked in Q3 2026 at 3.81M shares.
Which other funds hold ENGN?
Other major institutional holders of ENGN include FCPM III SERVICES B.V., BML Capital Management, LLC, Nextech Invest Ltd., among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.